Year: 2019
Type: book-chapter
Abstract: Living in a time when population is continuously ageing, the challenge and demand for assessing the age-related pathways, potential diseases and longevity have become of major interest. The pharmaceutical industry possesses huge resources in this field, mainly due to the recent discoveries of novel mechanisms of action of old-established, classical drugs. Here we find metformin, a well-established antidiabetic medicine but with new potential benefits, as the most recent reports quote. We present the main pathways of the possible implications of metformin in the modulation of ageing processes, evolution and diseases, focussing on its ageing counteraction, based on the latest scientifically based biochemical reports.
Source: IntechOpen eBooks
Institutions: Iuliu Hațieganu University of Medicine and Pharmacy, University of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca, Instituto de Salud Carlos III, Instituto Maimónides de Investigación Biomédica de Córdoba, Centro de Investigación Biomédica en Red, University of Córdoba, Carol Davila University of Medicine and Pharmacy, Novo Nordisk (Denmark), Novo Nordisk (Switzerland), University of Palermo
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
Funder: Novo Nordisk
OpenAlex ID: W2996703667
